|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
She J, Yang P, Hong Q and Bai C: Lung
cancer in China: Challenges and interventions. Chest.
143:1117–1126. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang H, Zhu LJ, Yang YC, Wang ZX and Wang
R: MiR-224 promotes the chemoresistance of human lung
adenocarcinoma cells to cisplatin via regulating G1/S
transition and apoptosis by targeting p21(WAF1/CIP1). Br J Cancer.
111:339–354. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yan G, Yao R, Tang D, Qiu T, Shen Y, Jiao
W, Ge N, Xuan Y and Wang Y: Prognostic significance of microRNA
expression in completely resected lung adenocarcinoma and the
associated response to erlotinib. Med Oncol. 31:2032014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang K, Liang Q, Wei L, Zhang W and Zhu P:
MicroRNA-608 acts as a prognostic marker and inhibits the cell
proliferation in hepatocellular carcinoma by macrophage migration
inhibitory factor. Tumour Biol. 37:3823–3830. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hu J, Qiu M, Jiang F, Zhang S, Yang X,
Wang J, Xu L and Yin R: MiR-145 regulates cancer stem-like
properties and epithelial-to-mesenchymal transition in lung
adenocarcinoma-initiating cells. Tumour Biol. 35:8953–8961. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Johnnidis JB, Harris MH, Wheeler RT,
Stehling-Sun S, Lam MH, Kirak O, Brummelkamp TR, Fleming MD and
Camargo FD: Regulation of progenitor cell proliferation and
granulocyte function by microRNA-223. Nature. 451:1125–1129. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xing F, Wu K and Watabe K: MicroRNAs in
cancer stem cells: New regulators of stemness. Curr Pharm Des.
20:5319–5327. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qi J and Mu D: MicroRNAs and lung cancers:
From pathogenesis to clinical implications. Front Med. 6:134–155.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gu Y, Wang XD, Lu JJ, Lei YY, Zou JY and
Luo HH: Effect of mir-16 on proliferation and apoptosis in human
A549 lung adenocarcinoma cells. Int J Clin Exp Med. 8:3227–3233.
2015.PubMed/NCBI
|
|
11
|
Arima C, Kajino T, Tamada Y, Imoto S,
Shimada Y, Nakatochi M, Suzuki M, Isomura H, Yatabe Y, Yamaguchi T,
et al: Lung adenocarcinoma subtypes definable by lung
development-related miRNA expression profiles in association with
clinicopathologic features. Carcinogenesis. 35:2224–2231. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen DQ, Pan BZ, Huang JY, Zhang K, Cui
SY, De W, Wang R and Chen LB: HDAC 1/4-mediated silencing of
microRNA-200b promotes chemoresistance in human lung adenocarcinoma
cells. Oncotarget. 5:3333–3349. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Riffo-Campos ÁL, Riquelme I and
Brebi-Mieville P: Tools for Sequence-Based miRNA Target Prediction:
What to Choose? Int J Mol Sci. 17:pii: E1987. 2016. View Article : Google Scholar
|
|
15
|
Wang S, Zhao X, Wang J, Wen Y, Zhang L,
Wang D, Chen H, Chen Q and Xiang W: Upregulation of microRNA-203 is
associated with advanced tumor progression and poor prognosis in
epithelial ovarian cancer. Med Oncol. 30:6812013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu K, Ding H, Wang W, Liao Z, Fu Z, Hong
Y, Zhou Y, Zhang CY and Chen X: Tumor-suppressive miR-218-5p
inhibits cancer cell proliferation and migration via EGFR in
non-small cell lung cancer. Oncotarget. 7:28075–28085. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xiao P and Liu WL: MiR-142-3p functions as
a potential tumor suppressor directly targeting HMGB1 in
non-small-cell lung carcinoma. Int J Clin Exp Pathol.
8:10800–10807. 2015.PubMed/NCBI
|
|
18
|
Li YQ, Lu JH, Bao XM, Wang XF, Wu JH and
Hong WQ: MiR-24 functions as a tumor suppressor in nasopharyngeal
carcinoma through targeting FSCN1. J Exp Clin Cancer Res.
34:1302015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu T, Liu L, Li J, Yan M, Lin H, Liu Y,
Chu D, Tu H, Gu A and Yao M: MiRNA-10a is upregulated in NSCLC and
may promote cancer by targeting PTEN. Oncotarget. 6:30239–30250.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu F, Zhang H, Su Y, Kong J, Yu H and Qian
B: Up-regulation of microRNA-183-3p is a potent prognostic marker
for lung adenocarcinoma of female non-smokers. Clin Transl Oncol.
16:980–985. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen L, Guan H, Gu C, Cao Y, Shao J and
Wang F: miR-383 inhibits hepatocellular carcinoma cell
proliferation via targeting APRIL. Tumour Biol. 37:2497–2507. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Han S, Cao C, Tang T, Lu C, Xu J, Wang S,
Xue L, Zhang X and Li M: ROBO3 promotes growth and metastasis of
pancreatic carcinoma. Cancer Lett. 366:61–70. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
He Z, Cen D, Luo X, Li D, Li P, Liang L
and Meng Z: Downregulation of miR-383 promotes glioma cell invasion
by targeting insulin-like growth factor 1 receptor. Med Oncol.
30:5572013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lian J, Tian H, Liu L, Zhang XS, Li WQ,
Deng YM, Yao GD, Yin MM and Sun F: Downregulation of microRNA-383
is associated with male infertility and promotes testicular
embryonal carcinoma cell proliferation by targeting IRF1. Cell
Death Dis. 1:e942010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li KK, Pang JC, Lau KM, Zhou L, Mao Y,
Wang Y, Poon WS and Ng HK: MiR-383 is downregulated in
medulloblastoma and targets peroxiredoxin 3 (PRDX3). Brain Pathol.
23:413–425. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lü M, Tian H, Cao YX, He X, Chen L, Song
X, Ping P, Huang H and Sun F: Downregulation of
miR-320a/383-sponge-like long non-coding RNA NLC1-C (narcolepsy
candidate-region 1 genes) is associated with male infertility and
promotes testicular embryonal carcinoma cell proliferation. Cell
Death Dis. 6:e19602015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu Z, Zeng X, Tian D, Xu H, Cai Q, Wang J
and Chen Q: MicroRNA-383 inhibits anchorage-independent growth and
induces cell cycle arrest of glioma cells by targeting CCND1.
Biochem Biophys Res Commun. 453:833–838. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu N, He QM, Chen JW, Li YQ, Xu YF, Ren
XY, Sun Y, Mai HQ, Shao JY, Jia WH, et al: Overexpression of CIP2A
is an independent prognostic indicator in nasopharyngeal carcinoma
and its depletion suppresses cell proliferation and tumor growth.
Mol Cancer. 13:1112014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zheng Z, Qiao Z, Chen W, Gong R, Wang Y,
Xu L, Ma Y, Zhang L, Lu Y, Jiang B, et al: CIP2A regulates
proliferation and apoptosis of multiple myeloma cells. Mol Med Rep.
14:2705–2709. 2016.PubMed/NCBI
|
|
30
|
Liu Z, Ma L, Wen ZS, Cheng YX and Zhou GB:
Ethoxysanguinarine induces inhibitory effects and downregulates
CIP2A in lung cancer cells. ACS Med Chem Lett. 5:113–118. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu J, Wang M, Zhang X, Wang Q, Qi M, Hu
J, Zhou Z, Zhang C, Zhang W, Zhao W and Wang X: CIP2A is associated
with multidrug resistance in cervical adenocarcinoma by a
P-glycoprotein pathway. Tumour Biol. 37:2673–2682. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Junttila MR, Puustinen P, Niemelä M, Ahola
R, Arnold H, Böttzauw T, Ala-aho R, Nielsen C, Ivaska J, Taya Y, et
al: CIP2A inhibits PP2A in human malignancies. Cell. 130:51–62.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dong QZ, Wang Y, Dong XJ, Li ZX, Tang ZP,
Cui QZ and Wang EH: CIP2A is overexpressed in non-small cell lung
cancer and correlates with poor prognosis. Ann Surg Oncol.
18:857–865. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chao TT, Wang CY, Lai CC, Chen YL, Tsai
YT, Chen PT, Lin HI, Huang YC, Shiau CW, Yu CJ and Chen KF: TD-19,
an erlotinib derivative, induces epidermal growth factor receptor
wild-type nonsmall-cell lung cancer apoptosis through
CIP2A-mediated pathway. J Pharmacol Exp Ther. 351:352–358. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lei N, Peng B and Zhang JY: CIP2A
regulates cell proliferation via the AKT signaling pathway in human
lung cancer. Oncol Rep. 32:1689–1694. 2014.PubMed/NCBI
|
